VCEL Q4 2021 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+5.2% YoY

Gross Profit

$34M71.5% margin

Operating Income

$4M8.7% margin

Net Income

$5M9.5% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+37.9%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$244M

Total Liabilities

$73M

Stockholders' Equity

$170M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$45M	+5.2%
Gross Profit	$34M	$34M	+1.1%
Operating Income	$4M	$12M	-66.3%
Net Income	$5M	$12M	-62.9%